Skip to main content

Diabetic Nephropathy News

Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction

THURSDAY, June 26, 2025 – Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI),...

FDA Approves Arbli (losartan potassium) Oral Suspension as the First Ready-to-Use Oral Liquid Losartan in the U.S.

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) – Scienture Holdings, Inc. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value...

1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy

MONDAY, March 17, 2025 – The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online Feb. 21 in...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

lisinopril, losartan, ramipril, Invokana